Vigabatrin Market, Global Outlook and Forecast 2022-2028

March 2022 | 77 pages | ID: V6F1BB091CD2EN
Market Monitor Global

Abstracts

Vigabatrin is a medication used to treat epilepsy. It became available as a generic medication in 2019. It works by inhibiting the breakdown of ?-aminobutyric acid (GABA). It is also known as ?-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.

This report contains market size and forecasts of Vigabatrin in global, including the following market information:

Global Vigabatrin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vigabatrin Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Vigabatrin companies in 2021 (%)

The global Vigabatrin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vigabatrin include Sanofi, Benta Pharma Industries, Dr. Fisher Farma, Lundbeck, Novartis, Perrigo, Grindeks, Endo International and Amneal Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vigabatrin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vigabatrin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vigabatrin Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Powder

Global Vigabatrin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vigabatrin Market Segment Percentages, by Application, 2021 (%)

• Infantile Spasms (IS)
• Partial-Onset Seizures
• Refractory Complex Partial Seizures

Global Vigabatrin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vigabatrin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vigabatrin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vigabatrin revenues share in global market, 2021 (%)

Key companies Vigabatrin sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Vigabatrin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Benta Pharma Industries
• Dr. Fisher Farma
• Lundbeck
• Novartis
• Perrigo
• Grindeks
• Endo International
• Amneal Pharma
• Cipla
• Upsher-Smith

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vigabatrin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vigabatrin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VIGABATRIN OVERALL MARKET SIZE

2.1 Global Vigabatrin Market Size: 2021 VS 2028
2.2 Global Vigabatrin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Vigabatrin Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Vigabatrin Players in Global Market
3.2 Top Global Vigabatrin Companies Ranked by Revenue
3.3 Global Vigabatrin Revenue by Companies
3.4 Global Vigabatrin Sales by Companies
3.5 Global Vigabatrin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Vigabatrin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Vigabatrin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vigabatrin Players in Global Market
  3.8.1 List of Global Tier 1 Vigabatrin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Vigabatrin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Vigabatrin Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Powder
4.2 By Type - Global Vigabatrin Revenue & Forecasts
  4.2.1 By Type - Global Vigabatrin Revenue, 2017-2022
  4.2.2 By Type - Global Vigabatrin Revenue, 2023-2028
  4.2.3 By Type - Global Vigabatrin Revenue Market Share, 2017-2028
4.3 By Type - Global Vigabatrin Sales & Forecasts
  4.3.1 By Type - Global Vigabatrin Sales, 2017-2022
  4.3.2 By Type - Global Vigabatrin Sales, 2023-2028
  4.3.3 By Type - Global Vigabatrin Sales Market Share, 2017-2028
4.4 By Type - Global Vigabatrin Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vigabatrin Market Size, 2021 & 2028
  5.1.2 Infantile Spasms (IS)
  5.1.3 Partial-Onset Seizures
  5.1.4 Refractory Complex Partial Seizures
5.2 By Application - Global Vigabatrin Revenue & Forecasts
  5.2.1 By Application - Global Vigabatrin Revenue, 2017-2022
  5.2.2 By Application - Global Vigabatrin Revenue, 2023-2028
  5.2.3 By Application - Global Vigabatrin Revenue Market Share, 2017-2028
5.3 By Application - Global Vigabatrin Sales & Forecasts
  5.3.1 By Application - Global Vigabatrin Sales, 2017-2022
  5.3.2 By Application - Global Vigabatrin Sales, 2023-2028
  5.3.3 By Application - Global Vigabatrin Sales Market Share, 2017-2028
5.4 By Application - Global Vigabatrin Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vigabatrin Market Size, 2021 & 2028
6.2 By Region - Global Vigabatrin Revenue & Forecasts
  6.2.1 By Region - Global Vigabatrin Revenue, 2017-2022
  6.2.2 By Region - Global Vigabatrin Revenue, 2023-2028
  6.2.3 By Region - Global Vigabatrin Revenue Market Share, 2017-2028
6.3 By Region - Global Vigabatrin Sales & Forecasts
  6.3.1 By Region - Global Vigabatrin Sales, 2017-2022
  6.3.2 By Region - Global Vigabatrin Sales, 2023-2028
  6.3.3 By Region - Global Vigabatrin Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Vigabatrin Revenue, 2017-2028
  6.4.2 By Country - North America Vigabatrin Sales, 2017-2028
  6.4.3 US Vigabatrin Market Size, 2017-2028
  6.4.4 Canada Vigabatrin Market Size, 2017-2028
  6.4.5 Mexico Vigabatrin Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Vigabatrin Revenue, 2017-2028
  6.5.2 By Country - Europe Vigabatrin Sales, 2017-2028
  6.5.3 Germany Vigabatrin Market Size, 2017-2028
  6.5.4 France Vigabatrin Market Size, 2017-2028
  6.5.5 U.K. Vigabatrin Market Size, 2017-2028
  6.5.6 Italy Vigabatrin Market Size, 2017-2028
  6.5.7 Russia Vigabatrin Market Size, 2017-2028
  6.5.8 Nordic Countries Vigabatrin Market Size, 2017-2028
  6.5.9 Benelux Vigabatrin Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Vigabatrin Revenue, 2017-2028
  6.6.2 By Region - Asia Vigabatrin Sales, 2017-2028
  6.6.3 China Vigabatrin Market Size, 2017-2028
  6.6.4 Japan Vigabatrin Market Size, 2017-2028
  6.6.5 South Korea Vigabatrin Market Size, 2017-2028
  6.6.6 Southeast Asia Vigabatrin Market Size, 2017-2028
  6.6.7 India Vigabatrin Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Vigabatrin Revenue, 2017-2028
  6.7.2 By Country - South America Vigabatrin Sales, 2017-2028
  6.7.3 Brazil Vigabatrin Market Size, 2017-2028
  6.7.4 Argentina Vigabatrin Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Vigabatrin Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Vigabatrin Sales, 2017-2028
  6.8.3 Turkey Vigabatrin Market Size, 2017-2028
  6.8.4 Israel Vigabatrin Market Size, 2017-2028
  6.8.5 Saudi Arabia Vigabatrin Market Size, 2017-2028
  6.8.6 UAE Vigabatrin Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Vigabatrin Major Product Offerings
  7.1.4 Sanofi Vigabatrin Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 Benta Pharma Industries
  7.2.1 Benta Pharma Industries Corporate Summary
  7.2.2 Benta Pharma Industries Business Overview
  7.2.3 Benta Pharma Industries Vigabatrin Major Product Offerings
  7.2.4 Benta Pharma Industries Vigabatrin Sales and Revenue in Global (2017-2022)
  7.2.5 Benta Pharma Industries Key News
7.3 Dr. Fisher Farma
  7.3.1 Dr. Fisher Farma Corporate Summary
  7.3.2 Dr. Fisher Farma Business Overview
  7.3.3 Dr. Fisher Farma Vigabatrin Major Product Offerings
  7.3.4 Dr. Fisher Farma Vigabatrin Sales and Revenue in Global (2017-2022)
  7.3.5 Dr. Fisher Farma Key News
7.4 Lundbeck
  7.4.1 Lundbeck Corporate Summary
  7.4.2 Lundbeck Business Overview
  7.4.3 Lundbeck Vigabatrin Major Product Offerings
  7.4.4 Lundbeck Vigabatrin Sales and Revenue in Global (2017-2022)
  7.4.5 Lundbeck Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Vigabatrin Major Product Offerings
  7.5.4 Novartis Vigabatrin Sales and Revenue in Global (2017-2022)
  7.5.5 Novartis Key News
7.6 Perrigo
  7.6.1 Perrigo Corporate Summary
  7.6.2 Perrigo Business Overview
  7.6.3 Perrigo Vigabatrin Major Product Offerings
  7.6.4 Perrigo Vigabatrin Sales and Revenue in Global (2017-2022)
  7.6.5 Perrigo Key News
7.7 Grindeks
  7.7.1 Grindeks Corporate Summary
  7.7.2 Grindeks Business Overview
  7.7.3 Grindeks Vigabatrin Major Product Offerings
  7.7.4 Grindeks Vigabatrin Sales and Revenue in Global (2017-2022)
  7.7.5 Grindeks Key News
7.8 Endo International
  7.8.1 Endo International Corporate Summary
  7.8.2 Endo International Business Overview
  7.8.3 Endo International Vigabatrin Major Product Offerings
  7.8.4 Endo International Vigabatrin Sales and Revenue in Global (2017-2022)
  7.8.5 Endo International Key News
7.9 Amneal Pharma
  7.9.1 Amneal Pharma Corporate Summary
  7.9.2 Amneal Pharma Business Overview
  7.9.3 Amneal Pharma Vigabatrin Major Product Offerings
  7.9.4 Amneal Pharma Vigabatrin Sales and Revenue in Global (2017-2022)
  7.9.5 Amneal Pharma Key News
7.10 Cipla
  7.10.1 Cipla Corporate Summary
  7.10.2 Cipla Business Overview
  7.10.3 Cipla Vigabatrin Major Product Offerings
  7.10.4 Cipla Vigabatrin Sales and Revenue in Global (2017-2022)
  7.10.5 Cipla Key News
7.11 Upsher-Smith
  7.11.1 Upsher-Smith Corporate Summary
  7.11.2 Upsher-Smith Vigabatrin Business Overview
  7.11.3 Upsher-Smith Vigabatrin Major Product Offerings
  7.11.4 Upsher-Smith Vigabatrin Sales and Revenue in Global (2017-2022)
  7.11.5 Upsher-Smith Key News

8 GLOBAL VIGABATRIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Vigabatrin Production Capacity, 2017-2028
8.2 Vigabatrin Production Capacity of Key Manufacturers in Global Market
8.3 Global Vigabatrin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VIGABATRIN SUPPLY CHAIN ANALYSIS

10.1 Vigabatrin Industry Value Chain
10.2 Vigabatrin Upstream Market
10.3 Vigabatrin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Vigabatrin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Vigabatrin in Global Market
Table 2. Top Vigabatrin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Vigabatrin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Vigabatrin Revenue Share by Companies, 2017-2022
Table 5. Global Vigabatrin Sales by Companies, (K Units), 2017-2022
Table 6. Global Vigabatrin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Vigabatrin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Vigabatrin Product Type
Table 9. List of Global Tier 1 Vigabatrin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vigabatrin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vigabatrin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Vigabatrin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Vigabatrin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Vigabatrin Sales (K Units), 2017-2022
Table 15. By Type - Global Vigabatrin Sales (K Units), 2023-2028
Table 16. By Application – Global Vigabatrin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Vigabatrin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Vigabatrin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Vigabatrin Sales (K Units), 2017-2022
Table 20. By Application - Global Vigabatrin Sales (K Units), 2023-2028
Table 21. By Region – Global Vigabatrin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Vigabatrin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Vigabatrin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Vigabatrin Sales (K Units), 2017-2022
Table 25. By Region - Global Vigabatrin Sales (K Units), 2023-2028
Table 26. By Country - North America Vigabatrin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Vigabatrin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Vigabatrin Sales, (K Units), 2017-2022
Table 29. By Country - North America Vigabatrin Sales, (K Units), 2023-2028
Table 30. By Country - Europe Vigabatrin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Vigabatrin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Vigabatrin Sales, (K Units), 2017-2022
Table 33. By Country - Europe Vigabatrin Sales, (K Units), 2023-2028
Table 34. By Region - Asia Vigabatrin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Vigabatrin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Vigabatrin Sales, (K Units), 2017-2022
Table 37. By Region - Asia Vigabatrin Sales, (K Units), 2023-2028
Table 38. By Country - South America Vigabatrin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Vigabatrin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Vigabatrin Sales, (K Units), 2017-2022
Table 41. By Country - South America Vigabatrin Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Vigabatrin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Vigabatrin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Vigabatrin Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Vigabatrin Sales, (K Units), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Vigabatrin Product Offerings
Table 48. Sanofi Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Benta Pharma Industries Corporate Summary
Table 50. Benta Pharma Industries Vigabatrin Product Offerings
Table 51. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Dr. Fisher Farma Corporate Summary
Table 53. Dr. Fisher Farma Vigabatrin Product Offerings
Table 54. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Lundbeck Corporate Summary
Table 56. Lundbeck Vigabatrin Product Offerings
Table 57. Lundbeck Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Novartis Corporate Summary
Table 59. Novartis Vigabatrin Product Offerings
Table 60. Novartis Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Perrigo Corporate Summary
Table 62. Perrigo Vigabatrin Product Offerings
Table 63. Perrigo Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Grindeks Corporate Summary
Table 65. Grindeks Vigabatrin Product Offerings
Table 66. Grindeks Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Endo International Corporate Summary
Table 68. Endo International Vigabatrin Product Offerings
Table 69. Endo International Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Amneal Pharma Corporate Summary
Table 71. Amneal Pharma Vigabatrin Product Offerings
Table 72. Amneal Pharma Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Cipla Corporate Summary
Table 74. Cipla Vigabatrin Product Offerings
Table 75. Cipla Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Upsher-Smith Corporate Summary
Table 77. Upsher-Smith Vigabatrin Product Offerings
Table 78. Upsher-Smith Vigabatrin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Vigabatrin Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Vigabatrin Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Vigabatrin Production by Region, 2017-2022 (K Units)
Table 82. Global Vigabatrin Production by Region, 2023-2028 (K Units)
Table 83. Vigabatrin Market Opportunities & Trends in Global Market
Table 84. Vigabatrin Market Drivers in Global Market
Table 85. Vigabatrin Market Restraints in Global Market
Table 86. Vigabatrin Raw Materials
Table 87. Vigabatrin Raw Materials Suppliers in Global Market
Table 88. Typical Vigabatrin Downstream
Table 89. Vigabatrin Downstream Clients in Global Market
Table 90. Vigabatrin Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Vigabatrin Segment by Type
Figure 2. Vigabatrin Segment by Application
Figure 3. Global Vigabatrin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vigabatrin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vigabatrin Revenue, 2017-2028 (US$, Mn)
Figure 7. Vigabatrin Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vigabatrin Revenue in 2021
Figure 9. By Type - Global Vigabatrin Sales Market Share, 2017-2028
Figure 10. By Type - Global Vigabatrin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Vigabatrin Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Vigabatrin Sales Market Share, 2017-2028
Figure 13. By Application - Global Vigabatrin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Vigabatrin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Vigabatrin Sales Market Share, 2017-2028
Figure 16. By Region - Global Vigabatrin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Vigabatrin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Vigabatrin Sales Market Share, 2017-2028
Figure 19. US Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Vigabatrin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Vigabatrin Sales Market Share, 2017-2028
Figure 24. Germany Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 25. France Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Vigabatrin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Vigabatrin Sales Market Share, 2017-2028
Figure 33. China Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 37. India Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Vigabatrin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Vigabatrin Sales Market Share, 2017-2028
Figure 40. Brazil Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Vigabatrin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Vigabatrin Sales Market Share, 2017-2028
Figure 44. Turkey Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Vigabatrin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Vigabatrin Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Vigabatrin by Region, 2021 VS 2028
Figure 50. Vigabatrin Industry Value Chain
Figure 51. Marketing Channels